JACLYN NASTRO: Open Payments
NPI 1023496130 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,203 in 96 payments from 18 companies in 2025. Trend: 2023 $2,365 · 2024 $1,183 · 2025 $2,203
Food & beverage: $2,099Education: $104
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 11 | $299 |
| Janssen Biotech, Inc. | 12 | $281 |
| Galderma Laboratories, L.P. | 9 | $268 |
| ABBVIE INC. | 12 | $191 |
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $148 |
| UCB, Inc. | 6 | $138 |
| Amgen Inc. | 6 | $122 |
| PFIZER INC. | 6 | $107 |
| Lilly USA, LLC | 3 | $84 |
Products named: OPZELURA, TREMFYA, NEMLUVIO, DUPIXENT, COSENTYX, Bimzelx, OTEZLA, CIBINQO.
Industry payments across NY — which companies pay providers there.
